BioMarin's Roctavian gene therapy shows long-term effectiveness in treating severe hemophilia A, reducing bleeding and ...

Humana has released details about additional, upcoming organizational improvements to encourage a faster prior authorization ...

Replimune's RP1 treatment for advanced melanoma faces FDA rejection due to trial design issues, despite promising results ...

Audere is closing gaps in HIV care and education with the help of Amy, their artificial intelligence companion designed to ...

Sarepta officials said the temporary halt in shipments was done to maintain a productive working relationship with regulators ...

The Vision Center at Children’s Hospital Los Angeles is developing a protocol for a phase 1 clinical trial for the first gene ...

An expert discusses how choosing between triplet and quadruplet regimens for transplant-ineligible multiple myeloma depends on patient fitness, disease risk, and treatment tolerability. He highlights ...